The Department of Medical Services (DMS) has admitted that the department has struggled to supply sufficient numbers of Favipiravir pills for the treatment of Covid-19 patients to some areas after the recent surge in cases.
Dr Natthaphong Wongwiwat, deputy director-general of the DMS, said that Favipiravir is currently being both produced and imported by the Government Pharmaceutical Organization (GPO) to meet demand, but the current spike and growing demand for the pills had stretched all available resources at present.
“However, distribution will return to normal after March 3 [Thursday] because many more pills will be added into the system,” said Dr Natthaphong.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
